PD Program Was Successful in Hong Kong
PD Program Was Successful in Hong Kong
PD Program Was Successful in Hong Kong
Kong
Introduction
History of present illness
Mr. Wong was a 46-year old man. He defaulted current follow up and 2 days continuous ambulatory
peritoneal dialysis (CAPD). On admission, his blood pressure (BP) was 197/106mmHg, pulse was
108/min, oxygen saturation was 94% in room air, body temperature was 36.5 degree Celsius, body
height was 1.78 m, and body weight was 82.3 kg (body mass index was 26.0kg/m2). Glasgow Coma
Scale (GCS) was E4; V5; M6 (E4: Open eyes spontaneously; V5: Oriented, converses normally; M6:
Obey commands). His chief complaints were fatigue, shortness of breath, dyspnea on exertion at
this admission.
From this preliminary data, the following literature review and nursing assessment was trying to
understand anemia in CAPD client.
Literature review
Demographics of the end-stage renal disease
population
The World Health Organization (WHO) had already recognized that renal disease was a public
health issue. In 2000, there were about 1.5 million patients globally on dialysis; in 2010, this number
was projected to increase to 2.5 million, a 7% increase year on year. A similar trend was being
observed in Hong Kong. The incidence of end-stage renal failure (ESRF) requiring replacement
therapy had increased significantly around the world. Data from the United States Renal Data
System (USRDS) for the year 2005 showed that Taiwan had an annual incidence of 404 new cases
per million population (pmp), the highest in the world. In Hong Kong, the annual incidence was 173
new cases pmp in 2005, taking the 13th place in the USRDS data. The prevalence was 965 uremic
patients pmp requiring treatment in Hong Kong in 2005. For the age group of 2044, Hong Kong
ranked number 4 with 88 new cases pmp. For the age group of 4564, Hong Kong ranked number 5
with 289 new cases pmp (USRDS, 2007). This signified that renal disease was common in our
relatively younger population. Prevalence and incidence in 2007 were respectively 1026 and 164
pmp according to the Hong Kong Renal
Registry
. Prevailing causes of chronic kidney disease (CKD) in Hong Kong were diabetes (23%),
glomerulonephritis (GN, 34%) and hypertension (7%) for existing renal replacement therapy
(RRT) patients surveyed in 2007 (Lam, 2009). This had prompted the development of strategies
aimed at preventing the development and progression of asymptomatic CKD. Rising demand for
dialysis therapy and its associated costs were placing an unsustainable financial burden on public
sector health care budgets in countries all over the world, which carried profound implications
for health care financing in the near future. The predicted dialysis cost globally would increase to
about US$1.1 trillion for the decade of 20012010, compared with about US$500 billion spent
for the last decade worldwide. An ideal renal replacement therapy should have optimal survival,
lowest possible risk for comorbidity, highest level of quality of life and, equally important,
acceptable cost for society. Viable solutions were urgently needed in managing the treatment of
end-stage renal disease (ESRD) and controlling spending on ESRD without compromising the
quality of patient care. The policy model used in Hong Kong was using CAPD first, was also
being considered by other countries as an appealing cost-effective modality. The overall survival
of peritoneal dialysis (PD) patients in PWH was very respectable, with a 2-year patient survival
of 91% and technique survival of 82%. With an increasing number of elderly ESRD patients, the
2-year and 5- year patient survival rates for the elderly group in PD program were 89.3% and
54.8%, respectively, which were comparable to the rate of survival in the non-elderly group.
There were good reasons for why the PD program was successful in Hong Kong (Li, 2008).